Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nwe Ni

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Nagoya Journal of Medical Science|December 28, 2018
Myanmar language version of the Revised Hasegawa's Dementia ScaleYu Mon Saw, Thet Mon Than, Ei Mon Win, et al.
JMIR Research Protocols|May 31, 2023
The Fatty Liver, Cirrhosis, and Liver Cancer Study (TENDENCY): Protocol for a Multicenter Case-Control StudyYaqza Hussain, Ayman Bannaga, Neil Fisher, et al.
Gastroenterology|April 2, 2017
Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce FibrosisAndrew King, Diarmaid D Houlihan, Dean Kavanagh, et al.
Plos One|November 7, 2017
Helicobacter pylori bab characterization in clinical isolates from Bhutan, Myanmar, Nepal and BangladeshShamshul Ansari, Evariste Tshibangu Kabamba, Pradeep Krishna Shrestha, et al.
Liver Cancer|May 8, 2025
Current Surveillance Strategy Is Less Effective for Detecting Early-Stage Hepatocellular Carcinoma in Patients with Non-Viral and Non-Cirrhotic Liver DiseaseJessica Spiers, Wenhao Li, Aloysious D Aravinthan, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2017
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trialPhilip Noel Newsome, Richard Fox, Andrew L King, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis GroupNwe Ni Than, James Hodson, Daniel Schmidt-Martin, et al.
The Lancet. Gastroenterology & Hepatology|May 3, 2026
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensusJeremy F Cobbold, Hamish Miller, Kate Hallsworth, et al.
Journal of Gastroenterology and Hepatology|February 18, 2022
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' ConsortiumRupa Banerjee, Partha Pal, Ida Hilmi, et al.
Helicobacter|November 14, 2025
Management of Helicobacter pylori Infection: Myanmar Consensus ReportThan Than Aye, Nwe Ni, Tin Tin May, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Nagoya Journal of Medical Science|December 28, 2018
Myanmar language version of the Revised Hasegawa's Dementia ScaleYu Mon Saw, Thet Mon Than, Ei Mon Win, et al.
JMIR Research Protocols|May 31, 2023
The Fatty Liver, Cirrhosis, and Liver Cancer Study (TENDENCY): Protocol for a Multicenter Case-Control StudyYaqza Hussain, Ayman Bannaga, Neil Fisher, et al.
Gastroenterology|April 2, 2017
Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce FibrosisAndrew King, Diarmaid D Houlihan, Dean Kavanagh, et al.
Plos One|November 7, 2017
Helicobacter pylori bab characterization in clinical isolates from Bhutan, Myanmar, Nepal and BangladeshShamshul Ansari, Evariste Tshibangu Kabamba, Pradeep Krishna Shrestha, et al.
Liver Cancer|May 8, 2025
Current Surveillance Strategy Is Less Effective for Detecting Early-Stage Hepatocellular Carcinoma in Patients with Non-Viral and Non-Cirrhotic Liver DiseaseJessica Spiers, Wenhao Li, Aloysious D Aravinthan, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2017
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trialPhilip Noel Newsome, Richard Fox, Andrew L King, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis GroupNwe Ni Than, James Hodson, Daniel Schmidt-Martin, et al.
The Lancet. Gastroenterology & Hepatology|May 3, 2026
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensusJeremy F Cobbold, Hamish Miller, Kate Hallsworth, et al.
Journal of Gastroenterology and Hepatology|February 18, 2022
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' ConsortiumRupa Banerjee, Partha Pal, Ida Hilmi, et al.
Helicobacter|November 14, 2025
Management of Helicobacter pylori Infection: Myanmar Consensus ReportThan Than Aye, Nwe Ni, Tin Tin May, et al.
Pageof 4